December 28th 2020, 2:00pm
A report published by the Personalized Medicine Coalition shows that the number of personalized medicines on the market grew at the highest rate ever recorded by the organization from 2016-2020.
December 27th 2020, 3:00pm
During the panel on precision medicine at the Quality Cancer Care Alliance (QCCA) Fall Leadership Summit, the speakers discussed testing every patient upfront with a broad molecular assessment and bringing clinical research to the patient.
December 27th 2020, 11:30am
A top-5 roundup of some of 2020's advancements in the precision oncology space.
December 22nd 2020, 7:40pm
A report published by the Personalized Medicine Coalition (PMC) shows that the number of personalized medicines on the market is growing at the highest rate ever recorded by the organization.
December 20th 2020, 11:00am
Managing the constantly evolving selection of therapies in oncology can be difficult, but is of the utmost importance to get the right treatment to the right patient, agreed a panel at Patient-Centered Oncology Care® 2020.
December 18th 2020, 10:00pm
A new study validates the application of duplex sequencing in detecting mutations caused by chemical carcinogens.
December 18th 2020, 11:00am
According to the final panel at Patient-Centered Oncology Care®, clinical pathways can create a new problem: if each payer tries to impose its own pathways, it’s an administrative and ethical nightmare.
December 13th 2020, 2:30pm
The Caris Precision Oncology Alliance has brought together academic institutions and community practices with the goal of performing research and exchanging evidence and ideas for new types of tests, said W. Michael Korn, MD.
December 12th 2020, 7:45pm
The findings help explain why costly CAR T-cell therapy does not work for some patients.
December 7th 2020, 7:30pm
Data presented at the 62nd Annual ASH Meeting demonstrated the clinical utility of Adaptive Biotechnologies’ clonoSEQ next-generation sequencing to detect MRD in multiple myeloma patients.
